Ocugen, Inc. (OCGN)
0.9547
-0.02
(-2.32%)
USD |
NASDAQ |
Oct 09, 16:00
0.9547
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Operations (Quarterly) : -12.20M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.20M |
| March 31, 2026 | -21.79M |
| December 31, 2025 | -13.96M |
| September 30, 2025 | -12.92M |
| June 30, 2025 | -10.73M |
| March 31, 2025 | -19.36M |
| December 31, 2024 | -10.36M |
| September 30, 2024 | -11.27M |
| June 30, 2024 | -9.911M |
| March 31, 2024 | -10.60M |
| December 31, 2023 | -11.30M |
| September 30, 2023 | -13.71M |
| June 30, 2023 | -18.81M |
| March 31, 2023 | -18.24M |
| December 31, 2022 | -16.91M |
| September 30, 2022 | -14.30M |
| June 30, 2022 | -13.80M |
| March 31, 2022 | -15.07M |
| December 31, 2021 | -12.80M |
| September 30, 2021 | -8.053M |
| June 30, 2021 | -21.80M |
| March 31, 2021 | -5.283M |
| December 31, 2020 | -4.282M |
| September 30, 2020 | -2.654M |
| June 30, 2020 | -3.086M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.686M |
| December 31, 2019 | -8.744M |
| September 30, 2019 | -2.118M |
| June 30, 2019 | -3.364M |
| March 31, 2019 | -2.667M |
| December 31, 2018 | -2.786M |
| September 30, 2018 | -6.918M |
| June 30, 2018 | -5.213M |
| March 31, 2018 | 3.286M |
| December 31, 2017 | -4.319M |
| September 30, 2017 | -5.727M |
| June 30, 2017 | -5.629M |
| March 31, 2017 | -7.345M |
| December 31, 2016 | -5.893M |
| September 30, 2016 | -5.459M |
| June 30, 2016 | -6.543M |
| March 31, 2016 | -7.841M |
| December 31, 2015 | -6.997M |
| September 30, 2015 | -6.882M |
| June 30, 2015 | -7.466M |
| March 31, 2015 | -8.689M |
| December 31, 2014 | -5.145M |
| September 30, 2014 | -2.795M |
| June 30, 2014 | -5.446M |
| March 31, 2014 | -5.019M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Anika Therapeutics, Inc. | -0.684M |
| Gilead Sciences, Inc. | 3.573B |
| MannKind Corp. | -18.63M |
| Nektar Therapeutics | -75.77M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | 80.37M |
| Free Cash Flow | -61.02M |
| Free Cash Flow Per Share (Quarterly) | -0.0361 |
| Free Cash Flow to Equity (Quarterly) | -66.91M |
| Free Cash Flow to Firm (Quarterly) | -7.743M |
| Free Cash Flow Yield | -19.93% |